In addition, the combined inhibition of AURKA and WEE1 led to a synergistic increase in the death of KRAS-mutated lung cancer cells with acquired resistance to sotorasib, even greater than sotorasib plus VIC-1911 (63). The gene discussed is AURKA; the disease is lung carcinoma.